Skip to main content

Table 1 Baseline characteristics of the study population

From: Effects of real-time remote cardiac rehabilitation on exercise capacity and quality of life: a quasi-randomised controlled trial

 

Remote CR

Hospital CR

Mean ± SD

Mean ± SD

Disease HF/AMI for PCI/Post CS

13 / 2 / 1

14 / 0 / 1

COVID-19 vaccine inoculated (%)/unvaccinated (%)

10 (62)/6 (38)

8 (53)/7 (47)

Distance (between home and hospital) (km)

6.77 ± 7.1

5.51 ± 7.7

Dropout (%)

2/18 (11)

5/20 (25)

Men (%)/women (%)

7 (43)/9 (57)

12 (80)/3 (20)

Age

72.2 ± 10.4

77.3 ± 4.8

Height (cm)

156.1 ± 9.9

156.9 ± 8.5

Weight (kg)

58.8 ± 9.7

58.4 ± 11.3

BMI

24.1 ± 3.4

23.6 ± 3.2

CPX

 Peak VO2 (mL/min/kg)

12.0 ± 2.7

11.4 ± 2.8

 VT V-slope (mL/min/kg)

8.9 ± 2.0

9.1 ± 2.5

 VT trend (mL/min/kg)

8.6 ± 1.6

8.5 ± 2.2

 Peak watt

59.7 ± 17.8

56.3 ± 23.7

 Peak R

1.1 ± 0.1

1.1 ± 0.1

 VE vs VCO2

31.6 ± 6.4

33.5 ± 6.9

 R Knee joint extension muscle strength (kgf)

21.1 ± 9.2

20.3 ± 6.4

 6MWD (m)

327.5 ± 105.9

298.3 ± 99.7

 R Grip strength (kg)

24.1 ± 7.8

21.4 ± 6.4

Echocardiography

 LVEF (%)

59.2 ± 7.2

58.0 ± 7.6

 AOD (mm)

35.3 ± 4.8

35.5 ± 5.7

 LAD (mm)

41.7 ± 6.7

39.9 ± 5.2

 IVSd (mm)

11.1 ± 2.7

11.8 ± 3.2

 IVSs (mm)

12.6 ± 2.5

13.0 ± 2.5

 LVDd (mm)

47.8 ± 7.6

47.2 ± 7.9

 LVDs (mm)

33.1 ± 7.6

33.3 ± 8.5

 SV (ml)

63.2 ± 20.2

60.0 ± 22.5

Drawing blood

 BNP (pg/ml)

119.4 ± 111.3

115.8 ± 115

 eGFR (ml/min/1.73m2)

54.8 ± 22.2

59.8 ± 18.5

 BUN (mg/dl)

21.9 ± 9.8

18.7 ± 7.8

 Cr (mg/dl)

1.4 ± 1.9

0.9 ± 0.3

 Albumin (g/dl)

4.0 ± 0.5

4.0 ± 0.5

WHOQOL-BREF

 Physical health (point)

20.3 ± 4.5

20.1 ± 4.7

 Psychological health (point)

17.1 ± 3.4

16.3 ± 3.5

 Social relationships (point)

10.0 ± 1.9

8.2 ± 3.0

 Environment (point)

25.5 ± 4.1

22.5 ± 5.2

 Total (point)

77.4 ± 12.9

71.7 ± 16.4

WHODAS2.0-J

 Cognition (point)

10.0 ± 11.2

16.7 ± 30.0

 Mobility (point)

21.4 ± 21.2

17.0 ± 20.2

 Self-care (point)

13.3 ± 24.6

12.8 ± 19.7

 Social interactions (point)

22.3 ± 21.2

22.7 ± 20.2

 Life activities (point)

36.8 ± 27.0

26.0 ± 25.8

 Participation (point)

28.6 ± 22.7

24.4 ± 25.7

 Total (point)

21.6 ± 14.3

19.3 ± 21.8

  1. Preintervention physical and mental function, echocardiographic ultrasound, and blood test results
  2. BMI body mass index, CPX cardiopulmonary exercise test, Peak VO2 maximum oxygen uptake; V-slope method: rising point of VCO2 relative to VO; VEQ method: Point of increase in the ventilatory equivalent of oxygen (VE/VO2) without a concurrent increase in the ventilatory equivalent of carbon dioxide (VE/VCO2), VE vs VCO2 minute ventilation vs carbon dioxide production, 6MWD 6 min walk distance, LVEF left ventricular ejection fraction, AOD aortic root diameter, LAD left atrial dimension, IVSd diastolic interventricular septum, IVSs systolic interventricular septum, LVDd left ventricular end-diastolic dimension, LVDs left ventricular internal dimension in systole, SV left ventricular stroke volume, BNP brain (B type) natriuretic peptide, Egfr estimated glomerular filtration rate, BUN blood urea nitrogen, Cr creatinine, HF heart failure, AMI acute myocardial infarction, PCI percutaneous coronary intervention, CS cardiac surgery